Heparin sodium and Hydroxyurea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Heparin sodium (heparin sodium) and Hydroxyurea (hydroxyurea). Common drug interactions include cerebral atrophy among females and aplastic anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Heparin sodium and Hydroxyurea. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Heparin sodium?

Heparin sodium has active ingredients of heparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 21,065 Heparin sodium users. Check the latest studies of Heparin sodium.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

48 people who take Heparin sodium and Hydroxyurea together, and have interactions are studied.

Heparin sodium and Hydroxyurea drug interactions.

What are the common drug interactions of Heparin Sodium and Hydroxyurea, by gender? *:

female:

  1. Cerebral atrophy (decrement in size of brain)
  2. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Constipation
  5. Disinhibition (loss of inhibition)
  6. Feeling jittery
  7. General physical health deterioration (weak health status)
  8. Hyporeflexia (a condition of below normal or absent reflexes)
  9. Hypoxia (low oxygen in tissues)
  10. Hypoxic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)

male:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Diarrhoea
  3. Confusional state
  4. Constipation
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  7. Parkinson's disease
  8. Aggression
  9. Chest pain
  10. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)

What are the common drug interactions of Heparin Sodium and Hydroxyurea, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Diarrhoea
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Insomnia (sleeplessness)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Abdominal pain
  8. Mucosal inflammation (infection of mucous membrane)
  9. Pyrexia (fever)
  10. Decreased appetite

20-29:

  1. Haematoma (collection of blood outside the blood vessels)
  2. Swelling
  3. Wound dehiscence (a surgical incision reopens either internally or externally)

30-39:

  1. Anaemia (lack of blood)
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Splenic infarction (tissue damage of spleen)
  4. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

40-49:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Hepatic failure (liver failure)
  3. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  4. Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
  5. Hyperglycaemia (high blood sugar)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  8. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  9. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  10. Multi-organ failure (multisystem organ failure)

50-59:

  1. Abdominal pain
  2. Acute respiratory failure
  3. Asthenia (weakness)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Bradycardia (abnormally slow heart action)
  6. Cardiac failure congestive
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Coma (state of unconsciousness lasting more than six hours)
  9. Decreased appetite
  10. Diarrhoea

60+:

  1. Hallucination (an experience involving the perception of something not present)
  2. Constipation
  3. Dementia (madness)
  4. Gait disturbance
  5. Hallucination, visual (seeing things that aren't there)
  6. Pain in extremity
  7. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  8. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  9. Skin ulcer
  10. Atrioventricular block complete (heart block complete)

What are the existing conditions these people have? *

  1. Pneumonia: 6 people, 12.50%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 12.50%
  3. Thrombocytopenia (decrease of platelets in blood): 5 people, 10.42%
  4. Parkinson's Disease: 4 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Heparin sodium and Hydroxyurea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Heparin sodium and Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Heparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Heparin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyurea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium and hydroxyurea (the active ingredients of Heparin sodium and Hydroxyurea, respectively), and Heparin sodium and Hydroxyurea (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: